NK cell autoreactivity and autoimmune diseases

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Increasing evidences have pointed out the relevance of natural killer (NK) cells in organ-specific and systemic autoimmune diseases. NK cells bear a plethora of activating and inhibiting receptors that can play a role in regulating reactivity with autologous cells. The activating receptors recognize natural ligands up-regulated on virus-infected or stressed or neoplastic cells. Of note, several autoimmune diseases are thought to be linked to viral infections as one of the first event in inducing autoimmunity. Also, it is conceivable that autoimmunity can be triggered when a dysregulation of innate immunity occurs, activating T and B lymphocytes to react with self-components. This would imply that NK cells can play a regulatory role during adaptive immunity; indeed, innate lymphoid cells (ILCs), comprising the classical CD56+ NK cells, have a role in maintaining or alternating tissue homeostasis secreting protective and/or pro-inflammatory cytokines. In addition, NK cells display activating receptors involved in natural cytotoxicity and the activating isoforms of receptors for HLA class I that can interact with healthy host cells and induce damage without any evidence of viral infection or neoplastic-induced alteration. In this context, the interrelationship among ILC, extracellular-matrix components, and mesenchymal stromal cells can be considered a key point for the control of homeostasis. Herein, we summarize evidences for a role of NK cells in autoimmune diseases and will give a point of view of the interplay between NK cells and self-cells in triggering autoimmunity.

Original languageEnglish
Article numberArticle 27
JournalFrontiers in Immunology
Volume5
Issue numberFEB
DOIs
Publication statusPublished - 2014

Fingerprint

Natural Killer Cells
Autoimmune Diseases
Autoimmunity
Virus Diseases
Homeostasis
Lymphocytes
Natural Killer Cell Receptors
Adaptive Immunity
Mesenchymal Stromal Cells
Innate Immunity
Extracellular Matrix
Protein Isoforms
B-Lymphocytes
Cytokines
Ligands
Viruses
T-Lymphocytes

Keywords

  • Autoimmunity
  • Autoreactivity
  • DNAM1
  • LAIR1
  • Mesenchymal stromal cells
  • NK cells
  • NKG2D
  • Regulatory NK cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

NK cell autoreactivity and autoimmune diseases. / Poggi, Alessandro; Zocchi, Maria Raffaella.

In: Frontiers in Immunology, Vol. 5, No. FEB, Article 27, 2014.

Research output: Contribution to journalArticle

@article{43ac7a337c844d33a96dfd29f74f4eb4,
title = "NK cell autoreactivity and autoimmune diseases",
abstract = "Increasing evidences have pointed out the relevance of natural killer (NK) cells in organ-specific and systemic autoimmune diseases. NK cells bear a plethora of activating and inhibiting receptors that can play a role in regulating reactivity with autologous cells. The activating receptors recognize natural ligands up-regulated on virus-infected or stressed or neoplastic cells. Of note, several autoimmune diseases are thought to be linked to viral infections as one of the first event in inducing autoimmunity. Also, it is conceivable that autoimmunity can be triggered when a dysregulation of innate immunity occurs, activating T and B lymphocytes to react with self-components. This would imply that NK cells can play a regulatory role during adaptive immunity; indeed, innate lymphoid cells (ILCs), comprising the classical CD56+ NK cells, have a role in maintaining or alternating tissue homeostasis secreting protective and/or pro-inflammatory cytokines. In addition, NK cells display activating receptors involved in natural cytotoxicity and the activating isoforms of receptors for HLA class I that can interact with healthy host cells and induce damage without any evidence of viral infection or neoplastic-induced alteration. In this context, the interrelationship among ILC, extracellular-matrix components, and mesenchymal stromal cells can be considered a key point for the control of homeostasis. Herein, we summarize evidences for a role of NK cells in autoimmune diseases and will give a point of view of the interplay between NK cells and self-cells in triggering autoimmunity.",
keywords = "Autoimmunity, Autoreactivity, DNAM1, LAIR1, Mesenchymal stromal cells, NK cells, NKG2D, Regulatory NK cells",
author = "Alessandro Poggi and Zocchi, {Maria Raffaella}",
year = "2014",
doi = "10.3389/fimmu.2014.00027",
language = "English",
volume = "5",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "FEB",

}

TY - JOUR

T1 - NK cell autoreactivity and autoimmune diseases

AU - Poggi, Alessandro

AU - Zocchi, Maria Raffaella

PY - 2014

Y1 - 2014

N2 - Increasing evidences have pointed out the relevance of natural killer (NK) cells in organ-specific and systemic autoimmune diseases. NK cells bear a plethora of activating and inhibiting receptors that can play a role in regulating reactivity with autologous cells. The activating receptors recognize natural ligands up-regulated on virus-infected or stressed or neoplastic cells. Of note, several autoimmune diseases are thought to be linked to viral infections as one of the first event in inducing autoimmunity. Also, it is conceivable that autoimmunity can be triggered when a dysregulation of innate immunity occurs, activating T and B lymphocytes to react with self-components. This would imply that NK cells can play a regulatory role during adaptive immunity; indeed, innate lymphoid cells (ILCs), comprising the classical CD56+ NK cells, have a role in maintaining or alternating tissue homeostasis secreting protective and/or pro-inflammatory cytokines. In addition, NK cells display activating receptors involved in natural cytotoxicity and the activating isoforms of receptors for HLA class I that can interact with healthy host cells and induce damage without any evidence of viral infection or neoplastic-induced alteration. In this context, the interrelationship among ILC, extracellular-matrix components, and mesenchymal stromal cells can be considered a key point for the control of homeostasis. Herein, we summarize evidences for a role of NK cells in autoimmune diseases and will give a point of view of the interplay between NK cells and self-cells in triggering autoimmunity.

AB - Increasing evidences have pointed out the relevance of natural killer (NK) cells in organ-specific and systemic autoimmune diseases. NK cells bear a plethora of activating and inhibiting receptors that can play a role in regulating reactivity with autologous cells. The activating receptors recognize natural ligands up-regulated on virus-infected or stressed or neoplastic cells. Of note, several autoimmune diseases are thought to be linked to viral infections as one of the first event in inducing autoimmunity. Also, it is conceivable that autoimmunity can be triggered when a dysregulation of innate immunity occurs, activating T and B lymphocytes to react with self-components. This would imply that NK cells can play a regulatory role during adaptive immunity; indeed, innate lymphoid cells (ILCs), comprising the classical CD56+ NK cells, have a role in maintaining or alternating tissue homeostasis secreting protective and/or pro-inflammatory cytokines. In addition, NK cells display activating receptors involved in natural cytotoxicity and the activating isoforms of receptors for HLA class I that can interact with healthy host cells and induce damage without any evidence of viral infection or neoplastic-induced alteration. In this context, the interrelationship among ILC, extracellular-matrix components, and mesenchymal stromal cells can be considered a key point for the control of homeostasis. Herein, we summarize evidences for a role of NK cells in autoimmune diseases and will give a point of view of the interplay between NK cells and self-cells in triggering autoimmunity.

KW - Autoimmunity

KW - Autoreactivity

KW - DNAM1

KW - LAIR1

KW - Mesenchymal stromal cells

KW - NK cells

KW - NKG2D

KW - Regulatory NK cells

UR - http://www.scopus.com/inward/record.url?scp=84895541185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895541185&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2014.00027

DO - 10.3389/fimmu.2014.00027

M3 - Article

AN - SCOPUS:84895541185

VL - 5

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - FEB

M1 - Article 27

ER -